Disseminated_VBN Infection_NN Due_JJ to_TO Blastobacter_NP denitrificans_NNS following_VBG Routine_NP Appendectomy_NN in_IN an_DT Adolescent_JJ Until_IN now_RB ,_, Blastobacter_NP denitrificans_NNS has_VBZ not_RB been_VBN mentioned_VBN in_IN the_DT context_NN of_IN human_JJ infections_NNS ._SENT A_DT case_NN of_IN severe_JJ complication_NN caused_VBN by_IN B._NP denitrificans_NNS after_IN routine_JJ appendectomy_NN in_IN a_DT young_JJ girl_NN is_VBZ described_VBN and_CC confirms_VBZ this_DT organism_NN to_TO be_VB an_DT opportunistic_JJ human_JJ pathogen_NN ._SENT A_DT 12-year-old_JJ girl_NN was_VBD initially_RB admitted_VBN to_TO a_DT general_JJ hospital_NN for_IN a_DT routine_JJ appendectomy_NN ._SENT After_IN the_DT operation_NN ,_, she_PP presented_VBD with_IN local_JJ abscesses_NNS and_CC pneumonia_NN accompanied_VBN by_IN severe_JJ effusions_NNS of_IN the_DT pleura_NNS and_CC pericardium_NN ._SENT The_DT girl_NN is_VBZ the_DT first_JJ child_NN of_IN healthy_JJ parents_NNS and_CC grew_VBD up_RP normally_RB ._SENT She_PP suffered_VBD from_IN bronchial_JJ asthma_NN ,_, but_CC no_DT immunological_JJ disorders_NNS were_VBD apparent_JJ ._SENT There_EX are_VBP two_CD more_JJR sisters_NNS and_CC two_CD twin_JJ brothers_NNS ._SENT One_CD of_IN her_PP$ sisters_NNS became_VBD deaf_JJ following_VBG an_DT episode_NN of_IN meningitis_NN ._SENT With_IN routine_JJ diagnostic_JJ methods_NNS ,_, we_PP found_VBD no_DT evidence_NN for_IN bacterial_JJ ,_, fungal_JJ ,_, or_CC viral_JJ infections_NNS to_TO explain_VB the_DT disseminated_VBN disease_NN after_IN the_DT appendectomy_NN ._SENT Clinical_JJ specimens_NNS during_IN her_PP$ stay_NN at_IN the_DT Center_NP of_IN Pediatrics_NP at_IN the_DT University_NP Hospital_NP (_( Magdeburg_NP ,_, Germany_NP )_) were_VBD reanalyzed_VBN for_IN microorganisms_NNS by_IN molecular_JJ techniques_NNS ._SENT We_PP performed_VBD a_DT broad-range_NN PCR_NP with_IN universal_JJ primers_NNS of_IN the_DT eubacterial_JJ 16S_JJ rRNA_NN gene_NN and_CC subsequently_RB sequenced_VBD this_DT gene_NN ._SENT Only_RB Blastobacter_NP denitrificans_NNS could_MD be_VB identified_VBN in_IN two_CD clinical_JJ specimens_NNS ,_, one_PP derived_VBD from_IN pneumonia-related_JJ effusion_NN and_CC the_DT other_JJ from_IN the_DT tip_NN of_IN the_DT central_JJ venous_JJ catheter_NN ._SENT The_DT analysis_NN was_VBD performed_VBN as_IN described_VBN previously_RB ;_: the_DT alignment_NN was_VBD 100_CD %_NN (_( BLAST_NP search_NN ,_, gb/946917.1/S46917_JJ )_) ._SENT Thereafter_RB ,_, an_DT aliquot_NN of_IN the_DT pneumonia-related_JJ effusion_NN that_WDT had_VBD been_VBN stored_VBN was_VBD plated_VBN onto_IN agar_NN medium_NN prepared_VBN as_IN described_VBN for_IN the_DT medium_JJ 1521_CD PYGV_NP (_( American_NP Type_NP Culture_NP Collection_NP ,_, Manassas_NP ,_, Va._NP ;_: )and_NN incubated_VBN at_IN 30C_JJ in_IN air_NN ._SENT After_IN 2_CD weeks_NNS of_IN cultivation_NN ,_, small_JJ colonies_NNS were_VBD evident_JJ on_IN plates_NNS ._SENT The_DT bacteria_NNS were_VBD gram-negative_JJ rods_NNS and_CC were_VBD positive_JJ for_IN urease_NN ,_, nitrate_NN reduction_NN (_( dissimilatory_JJ )_) ,_, esculin_NN hydrolysis_NN ,_, oxidase_NN ,_, and_CC catalase_NN ;_: the_DT test_NN for_IN indole_NN production_NN was_VBD negative_JJ ,_, and_CC acid_JJ production_NN from_IN d-glucose_NN was_VBD not_RB found_VBN ._SENT The_DT phenotyping_NN strongly_RB indicated_VBD that_IN the_DT organism_NN was_VBD an_DT alpha-proteobacterium_NN ._SENT The_DT identity_NN of_IN the_DT isolate_NN was_VBD subsequently_RB confirmed_VBN by_IN sequencing_VBG of_IN its_PP$ 16S_JJ rRNA_NN gene_NN ._SENT Until_IN now_RB ,_, the_DT interest_NN in_IN B._NP denitrificans_NNS was_VBD in_IN the_DT synthesis_NN of_IN pharmaceutical_JJ chemicals_NNS for_IN agriculture_NN or_CC in_IN chiral_JJ synthesis_NN of_IN compounds_NNS in_IN organic_JJ chemistry_NN ._SENT There_EX are_VBP no_DT clinical_JJ reports_NNS about_IN B._NP denitrificans_NNS as_IN a_DT human_JJ pathogen_NN in_IN a_DT healthy_JJ or_CC immunocompromised_JJ person_NN ._SENT This_DT may_MD be_VB due_JJ to_TO the_DT failure_NN of_IN routine_JJ diagnostic_JJ methods_NNS in_IN its_PP$ detection_NN ,_, since_IN culture_NN of_IN this_DT organism_NN is_VBZ difficult_JJ ._SENT B._NP denitrificans_NNS is_VBZ a_DT member_NN of_IN the_DT alpha-2_JJ subgroup_NN of_IN the_DT Proteobacteria_NP and_CC shows_VBZ a_DT very_RB close_JJ phylogenetic_JJ relationship_NN with_IN the_DT genus_NN Afipia_NN ._SENT In_IN addition_NN to_TO Bartonella_NP henselae_NNS ,_, the_DT microorganism_NN Afipia_NN felis_NP has_VBZ been_VBN correlated_VBN with_IN cat_NN scratch_NN disease_NN ._SENT Endocarditis_NN is_VBZ well_RB known_VBN to_TO be_VB a_DT complication_NN in_IN Bartonella_NP infections_NNS ,_, and_CC infections_NNS with_IN Afipia_NNS occur_VBP especially_RB in_IN immunocompromised_JJ patients_NNS ._SENT Also_RB ,_, after_IN reanalysis_NN of_IN the_DT clinical_JJ specimen_NN ,_, there_EX was_VBD no_DT indication_NN of_IN an_DT infection_NN with_IN Bartonella_NP spp._NPS There_EX is_VBZ only_RB some_DT information_NN about_IN the_DT antibiotic_JJ susceptibility_NN of_IN this_DT group_NN of_IN bacteria_NNS ._SENT For_IN A._NP felis_NP ,_, which_WDT is_VBZ a_DT facultative_JJ intracellular_JJ bacterium_NN and_CC multiplies_VBZ in_IN macrophages_NNS ,_, only_JJ aminoglycosides_NNS were_VBD found_VBN to_TO be_VB bactericidal_JJ ._SENT Bradyrhizobium_NN strains_NNS showed_VBD a_DT wide_JJ diversity_NN with_IN regard_NN to_TO intrinsic_JJ antibiotic_JJ resistance_NN ._SENT In_IN cases_NNS of_IN complicated_JJ cat_NN scratch_NN disease_NN caused_VBN by_IN Bartonella_NP henselae_NNS ,_, treatment_NN with_IN trimethoprim-sulfamethoxazole_NN ,_, ciprofloxacin_NN ,_, or_CC azithromycin_NN is_VBZ recommended_VBN ,_, with_IN gentamicin_NN being_VBG reserved_VBN for_IN severely_RB ill_JJ patients_NNS ._SENT In_IN the_DT reported_VBN case_NN ,_, therapy_NN lasted_VBD for_IN about_RB 1_CD month_NN and_CC included_VBD abdominal_JJ reoperation_NN (_( cecal_JJ abscess_NN formation_NN )_) and_CC pleural_JJ and_CC pericardial_JJ drainages_NNS after_IN appendectomy_NN ._SENT Several_JJ antibiotic_JJ regimens_NNS were_VBD implemented_VBN ._SENT In_IN this_DT regard_NN ,_, the_DT antibiotic_JJ therapy_NN was_VBD started_VBN in_IN the_DT general_JJ hospital_NN 1_CD week_NN after_IN routine_JJ appendectomy_NN ,_, when_WRB the_DT signs_NNS of_IN fever_NN ,_, local_JJ abscesses_NNS ,_, and_CC pleural_JJ empyema_NN appeared_VBD ._SENT A_DT combination_NN of_IN ceftriaxone_NN ,_, metronidazole_NN ,_, and_CC ampicillin_NN was_VBD applied_VBN initially_RB and_CC was_VBD changed_VBN to_TO ceftazidime_NN ,_, gentamicin_NN ,_, and_CC vancomycin_NP 5_CD days_NNS later_RBR ._SENT After_IN another_DT 5_CD days_NNS ,_, the_DT child_NN was_VBD transferred_VBN to_TO the_DT Center_NP of_IN Pediatrics_NP at_IN the_DT University_NP Hospital_NP (_( Magdeburg_NP ,_, Germany_NP )_) ._SENT The_DT antibiotic_JJ therapy_NN was_VBD changed_VBN to_TO a_DT combination_NN of_IN imipenem_NN ,_, gentamicin_NN ,_, and_CC vancomycin_NP for_IN a_DT period_NN of_IN 2_CD weeks_NNS ._SENT Ultimately_RB ,_, the_DT girl_NN left_VBD the_DT hospital_NN in_IN good_JJ condition_NN ._SENT To_TO get_VB some_DT information_NN about_IN the_DT antibiotic_JJ resistance_NN pattern_NN of_IN the_DT isolated_JJ B._NP denitrificans_NNS strain_VBP ,_, we_PP performed_VBD agar_NN diffusion_NN tests_NNS on_IN 1521_CD PYGV_NP agar_NN plates_NNS ;_: the_DT incubation_NN time_NN was_VBD 10_CD days_NNS ._SENT With_IN regard_NN to_TO the_DT applied_VBN antimicrobial_JJ substances_NNS ,_, the_DT strain_NN was_VBD sensitive_JJ only_RB to_TO imipenem_NN ._SENT This_DT is_VBZ the_DT first_JJ report_NN of_IN severe_JJ complication_NN caused_VBN by_IN B._NP denitrificans_NNS in_IN a_DT healthy_JJ person_NN and_CC confirms_VBZ the_DT potential_NN of_IN environmental_JJ bacteria_NNS to_TO cause_VB human_JJ disease_NN ._SENT FIG._NN 1_CD ._SENT |_SYM The_DT abdominal_JJ computer_NN tomography_NN of_IN the_DT patient_NN is_VBZ shown_VBN ._SENT The_DT abdominal_JJ computer_NN tomography_NN of_IN the_DT patient_NN is_VBZ shown_VBN ._SENT On_IN the_DT right_JJ side_NN of_IN the_DT patient_JJ (_( R_NN )_) an_DT organized_JJ abscess_NN with_IN necrotic_JJ tissue_NN and_CC fluid_NN is_VBZ visible_JJ ._SENT The_DT arrow_NN indicates_VBZ the_DT drainage_NN on_IN the_DT right_JJ side_NN ;_: the_DT drainage_NN lies_VBZ in_IN the_DT abscess_NN ending_VBG near_IN the_DT intestine_NN ,_, which_WDT is_VBZ filled_VBN with_IN contrast_NN medium_NN ._SENT 